DYSPNOEA EXERTIONAL
Adverse reaction reported in 21,957 FDA reports across 12 drugs.
21,957
Total Reports
12
Drugs Involved
Treprostinil
Most Reported Drug
Drugs Associated with DYSPNOEA EXERTIONAL
Drugs where "DYSPNOEA EXERTIONAL" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Treprostinil | 4,172 | |
| 2 | Ambrisentan | 2,537 | |
| 3 | Macitentan | 2,516 | |
| 4 | Tadalafil | 2,381 | |
| 5 | Oxygen | 1,628 | |
| 6 | 0xygen | 1,628 | |
| 7 | Sildenafil | 1,595 | |
| 8 | Riociguat | 1,532 | |
| 9 | Selexipag | 1,203 | |
| 10 | Nintedanib | 1,064 | |
| 11 | Epoprostenol | 962 | |
| 12 | Ciclesonide | 739 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused dyspnoea exertional. Always consult your healthcare provider.